DNA repair pathways, such as those involving RAD52 and INO80, are evolutionarily conserved, involved in genome instability and tumorigenesis [143], and predictive of therapeutic response in some cancers [144], thus representing potential tumor-specific biomarkers for chemotherapeutic efficacy. The gene discussed is RAD52; the disease is cancer.